机构:[1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China,神经内科首都医科大学宣武医院[2]Cell Therapy Center, Xuan Wu Hospital, Capital Medical University, and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing, China,首都医科大学宣武医院[3]Department of Neurological Surgery, Wayne State University School of Medicine, Taylor, MI, USA,[4]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, China
Objective: To determine the functional abnormalities of the Leu89Pro mutation in connexin32 (CX32), which we have previously reported is present within an X-linked dominant Charcot-Marie-Tooth disease family. In this family, male patients were moderately to severely affected. Methods: We performed immunofluorescence to investigate whether the Leu89Pro CX32 protein was transported to the cell membrane in HeLa and Schwann cells. First, we constructed the eukaryotic express plasmids expressing CX32 (wild-type or Leu89Pro) and enhanced green fluorescent protein by the gene recombination technology. Then the recombinant plasmids were transiently transfected into communication-incompetent HeLa cells and human Schwann cells by the lipofectamine method. Later, we double-labeled cells for both CX32 and markers of the ER (calnexin) or the Golgi (58-kDa protein) at 24 h or 48 h. The images were collected using a Leica TCS SP5 II confocal microscope. Results: The mutant CX32 protein was localized in the endoplasmic reticulum and failed to reach the cell membrane to form gap junctions. Conclusion: Our results indicated that the Leu89Pro substitution in the second transmembrane domain of CX32 disrupts the trafficking of the protein, inhibiting the assembly of CX32 gap junctions, which in turn may result in peripheral neuropathy. This functional abnormality may explain the moderate to severe phenotype seen in Leu89Pro patients, and as such represents a promising therapeutic target in the treatment of this subset of CMTX patients.
基金:
the National Natural Science Funds (grant number 81071000, 81422014)
the Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (No.KZ201410025023).
第一作者机构:[1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China,[*1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China.
通讯作者:
通讯机构:[*1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China.[*2]Xuan Wu Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
Yuwei Da,Wei Wang,Zhongfeng Liu,et al.Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease[J].NEUROLOGICAL RESEARCH.2016,38(10):897-902.doi:10.1080/01616412.2016.1204494.
APA:
Yuwei Da,Wei Wang,Zhongfeng Liu,Hai Chen,Li Di...&Zhiguo Chen.(2016).Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease.NEUROLOGICAL RESEARCH,38,(10)
MLA:
Yuwei Da,et al."Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease".NEUROLOGICAL RESEARCH 38..10(2016):897-902